Onkologinėmis ligomis sergančių moterų draugija "Eivena"

Company age: 18 y. 3 mo.

Update

Company overview

Company name Onkologinėmis ligomis sergančių moterų draugija "Eivena"
Company code 301745548
Registered address Kaunas, Eivenių g. 2, LT-50161
Registration date 2008-06-18 Company age: 18 y. 3 mo.
Phone Phone
Email Email
Revenue (2025) 15,352 € +29% History
Profit (2025) 0 € History
Number of employees 0
Managed vehicles 0
Current SODRA debt No debt Read more
Days of debt to SODRA per year 0 days
Current VMI debt No debt Read more
Financial statements All submitted
Legal form Association
NACE activity Activities of other membership organisations n.e.c.
Sector Namų ūkiams paslaugas teikiančios ne pelno institucijos
Ownership form Private without foreign capital
Beneficiary of support Yes, since 2008-06-18
NVO Non-governmental organization since 2020-12-17

Download a detailed company report

Make confident decisions with all the information about Onkologinėmis ligomis sergančių moterų draugija "Eivena". In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.

19.99 € + PVM Get report

Description

This description was generated by artificial intelligence.
Onkologinemis ligomis serganciu moteru draugija "Eivena" (company code 301745548) is an operational association registered in 2008. It is classified as a public, private-ownership, non-profit institution providing services to households, with governance described as CEO with board/council. The organisation is based in Kaunas, Kauno m. sav., Kauno apskr., at Eiveniu g. 2, LT-50161. Its registered activity is EVRK T.94.99.00, Activities of other membership organisations n.e.c. The entity is described as micro-sized. Financially, it remained small in scale: revenue reached EUR 15.4K in 2025, up 29.0% from 2024, but still below EUR 37.3K in 2023. Total assets stood at EUR 13.1K in 2025, compared with EUR 16.6K in 2024 and EUR 17.7K in 2023, while liabilities were EUR 174 in 2025. Staff information relates to so far in 2026.